Added to YB: 2025-07-22
Pitch date: 2025-07-20
DERM [bullish]
Journey Medical Corporation
+3.73%
current return
Author Info
The 10x Radar shares high-conviction small and microcap stock pitches with the potential to deliver multi-bagger returns. Sign up for the newsletter.
Company Info
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$177.0M
Pitch Price
$7.23
Price Target
N/A
Dividend
N/A
EV/EBITDA
119.72
P/E
-28.15
EV/Sales
2.60
Sector
Pharmaceuticals
Category
growth
Management Talks: Journey Medical — A Classic Execution Story in the Making
DERM: Emrosi (oral rosacea med) launched April 2025 already hitting 1,000 weekly scripts ($20M+ run rate). Break-even base biz ($55M+ annual) means Emrosi drops to bottom line. 65% commercial coverage secured. $200M+ peak sales target. 64% gross margins improving. $21M cash, FCF+ in 2025. Ex-Medicis team led by CEO owning 10%, built this before.
Read full article (5 min)